Literature DB >> 24410157

Predictive value of intraoperative 5-aminolevulinic acid-induced fluorescence for detecting bone invasion in meningioma surgery.

Alessandro Della Puppa1, Oriela Rustemi, Giorgio Gioffrè, Irene Troncon, Giuseppe Lombardi, Giuseppe Rolma, Massimo Sergi, Marina Munari, Diego Cecchin, Marina Paola Gardiman, Renato Scienza.   

Abstract

OBJECT: Bone invasion is a major concern in meningioma surgery, since it is predictive of the recurrence of cranial involvement, morbidity, and mortality. Bone invasion has been reported in 20%-68% of studies with histopathologically confirmed data. Unfortunately, radical resection of bone invasion remains challenging. The aim of this study was to assess the role of 5-aminolevulinic acid (5-ALA) fluorescence in guiding the resection of bone-invading meningiomas. To this purpose, the sensitivity, specificity, and positive and negative predictive values of 5-ALA in detecting meningioma bone invasion were evaluated.
METHODS: Data from 12 patients affected by bone-invading meningiomas (7 with skull base and 5 with convexity meningiomas) who had undergone surgery with the assistance of 5-ALA fluorescence and neuronavigation between July 2012 and March 2013 at the Department of Neurosurgery of Padua were retrospectively analyzed. To evaluate the sensitivity and specificity of 5-ALA fluorescence in detecting meningioma tissue, a pathologist analyzed 98 surgical bone samples under blue light, according to different fluorescence patterns. Magnetic resonance images and CT scans were obtained pre- and postoperatively to determine the extent of bone invasion resection.
RESULTS: The rate of 5-ALA-induced fluorescence of both tumor and bone invasion was 100%. Based on the pathological examination of bone specimens, 5-ALA presented a sensitivity of 89.06% (95% CI 81.41%-96.71%) and a specificity of 100% in detecting meningioma bone invasion, while the positive and negative predictive values were 100% and 82.93% (95% CI 71.41%-94.45%), respectively. At the postoperative stage, MRI did not detect cases of meningioma bone invasion, whereas CT scans revealed residual hyperostosis in 2 cases.
CONCLUSIONS: In summary, 5-ALA fluorescence represents a suitable and reliable technique for identifying and removing bone infiltration by meningiomas. However, further studies are needed to prove the clinical consequences of this promising technique in a larger population.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24410157     DOI: 10.3171/2013.12.JNS131642

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  23 in total

1.  Fluorescence-guided resection with 5-aminolevulinic acid of meningeal sarcoma in a child.

Authors:  Luis Miguel Bernal García; José Manuel Cabezudo Artero; Manuel Royano Sánchez; María Bella Marcelo Zamorano; María López Macías
Journal:  Childs Nerv Syst       Date:  2015-04-12       Impact factor: 1.475

2.  Folate Receptor Overexpression in Human and Canine Meningiomas-Immunohistochemistry and Case Report of Intraoperative Molecular Imaging.

Authors:  John T Pierce; Steve S Cho; Shayoni Nag; Ryan Zeh; Jun Jeon; David Holt; Amy Durham; MacLean P Nasrallah; Sunil Singhal; John Y K Lee
Journal:  Neurosurgery       Date:  2019-09-01       Impact factor: 4.654

Review 3.  5-Aminolevulinic Acid-Induced Protoporphyrin IX Fluorescence Imaging for Tumor Detection: Recent Advances and Challenges.

Authors:  Yoshinori Harada; Yasutoshi Murayama; Tetsuro Takamatsu; Eigo Otsuji; Hideo Tanaka
Journal:  Int J Mol Sci       Date:  2022-06-09       Impact factor: 6.208

Review 4.  5-aminolevulinic acid induced protoporphyrin IX (ALA-PpIX) fluorescence guidance in meningioma surgery.

Authors:  Pablo A Valdes; Matthias Millesi; Georg Widhalm; David W Roberts
Journal:  J Neurooncol       Date:  2019-01-02       Impact factor: 4.130

5.  Outcome of patients affected by newly diagnosed glioblastoma undergoing surgery assisted by 5-aminolevulinic acid guided resection followed by BCNU wafers implantation: a 3-year follow-up.

Authors:  Alessandro Della Puppa; Giuseppe Lombardi; Marta Rossetto; Oriela Rustemi; Franco Berti; Diego Cecchin; Marina Paola Gardiman; Giuseppe Rolma; Luca Persano; Vittorina Zagonel; Renato Scienza
Journal:  J Neurooncol       Date:  2016-10-18       Impact factor: 4.130

6.  The use of 5-aminolevulinic acid in resection of pediatric brain tumors: a critical review.

Authors:  Chenran Zhang; Frederick A Boop; John Ruge
Journal:  J Neurooncol       Date:  2018-11-15       Impact factor: 4.130

Review 7.  Various shades of red-a systematic analysis of qualitative estimation of ALA-derived fluorescence in neurosurgery.

Authors:  Marcel A Kamp; Zarela Krause Molle; Christopher Munoz-Bendix; Marion Rapp; Michael Sabel; Hans-Jakob Steiger; Jan F Cornelius
Journal:  Neurosurg Rev       Date:  2016-05-25       Impact factor: 3.042

Review 8.  The current status of 5-ALA fluorescence-guided resection of intracranial meningiomas-a critical review.

Authors:  Arash Motekallemi; Hanne-Rinck Jeltema; Jan D M Metzemaekers; Gooitzen M van Dam; Lucy M A Crane; Rob J M Groen
Journal:  Neurosurg Rev       Date:  2015-03-05       Impact factor: 3.042

Review 9.  Fluorescence-Guided Surgery: A Review on Timing and Use in Brain Tumor Surgery.

Authors:  Alexander J Schupper; Manasa Rao; Nicki Mohammadi; Rebecca Baron; John Y K Lee; Francesco Acerbi; Constantinos G Hadjipanayis
Journal:  Front Neurol       Date:  2021-06-16       Impact factor: 4.003

10.  Predicting the "usefulness" of 5-ALA-derived tumor fluorescence for fluorescence-guided resections in pediatric brain tumors: a European survey.

Authors:  Walter Stummer; Floriano Rodrigues; Philippe Schucht; Matthias Preuss; Dorothee Wiewrodt; Ulf Nestler; Marco Stein; José Manuel Cabezudo Artero; Nunzio Platania; Jane Skjøth-Rasmussen; Alessandro Della Puppa; John Caird; Søren Cortnum; Sam Eljamel; Christian Ewald; Laura González-García; Andrew J Martin; Ante Melada; Aurelia Peraud; Angela Brentrup; Thomas Santarius; Hans Herbert Steiner
Journal:  Acta Neurochir (Wien)       Date:  2014-09-24       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.